Its official ALTH to be taken over !!!!

Tell Bern's to kiss my ass, Jim C is BACK!!

 

unfortunately I hear it is Amag and not Biogen that is buying us! God help us.

 

What is amag?

 

Same track record. Stock down 50% since last year....from nearly 40 to 17. Berns record is just as bad from 8 to 2.80. Well done.

go to amagpharma.com to check out their web page. The symbolism is beautiful. There is a woman bending over a bike getting ready to be reamed from behind....

 

Q1 numbers next wk will be very disappointing, the end is near! Bern's and his executive team are idiots, they are done, its over!! Investor lawsuits are next, hope Bern's and his boy's are ready for some intense legal action, just one thing left to say, "your Fucked"

 

What are issues creating poor morale in the field force? Unrealistic quotas? Poor support from marketing? lack of compelling data?
If quotas are the issue, is it that it is difficult to get onc/hems to use it or are there not enough patients with PTCL? If it is poor support from marketing, is it a flawed value proposition story, lack of reimbursement support? other?

 

The issue is systemic. Berns and company believe in a big pharma business model of reach and frequency. Berns believes there are 10000 patients waiting for this drug and 5900 newly diagnosed cases of PTCL every year. The market is about 25% of this. These facts were told to senior leaders in September of 2009 and they were ignored or in most cases individuals who spoke out were forced out as non team players. Caruso rejected this information and Berns was forced to fire his only friend in the company.

PTCL is an ultra rare disease. Its not really treated in the community its treated by lymphoma specialists in academic centers or LPP clinics with deep research capabilities. When Schick or Berns go off on the quarterly conference calls about market penetration or account penetration they are simply trying to creat a perception that the market unfamiliar with folotyn. Its simply not true. Examine the oncbiz report on awareness and the data will show that everyone is familiar with PDX-they simply do not have the base of patients to routinely use it. No one will ever receive folotyn on 1st relapse, its at best a 2nd or 3rd or 4th tier product-thats it. When seagen or celgene truly start to compete its over for folotyn. Its not tolerated well and never has been. Its 65,000 per cycle and offers little to no survival benefit. PTCL is a tough disease to treat and chemically PDX looks and acts like Methotrexate so its a tough pill to swallow financially and clinically.

Its reimbursed it always been reimbursed, hell I dont even know why we ever had CADs anyway they are useless. Quotas are unattainable and management is unrealistic.

The mundipharm deal is sign of desparation. We need money to continue our FDA mandated trials to keep folotyn alive in the USA and sales will continue to flatten as the clinical experience of dose reduction and fewer and fewer patients take its toll on our revenues. The unwinding has already begun. Internally everyone has been hitting the panic button for at least a year because none of us thought wed still be around. Mundi bought planet earth for 50 Million and the promise of some royalties. Celgene bought gloucester for 340 Million and the same promise of royalties? Istodax wasnt FDA approved and its 6x as valuable as PDX? The fact the board allowed this type of deal to happen show how clueless they are as well.

 

This.

 

This can only be from someone inside the inner sanctum. Accurate as hell, BAGs is this you?

 

yep its me, Paul Bern's told me to tell the truth b/c he never does, and I did.

 

Thanks for your imput Garry allen; remember you were demoted from 2nd ball licker behind jim to 3rd testicle handler and anus sniffer. I bet your fingers have so much of balls ass on them that people can tell what paul had for lunch by smelling your key board. You're worthless. Go run another useless report.

 

ALTH needs to be taken over. Another 5 year low? Paul is incompetent, Mike is incompetent. The sales team hates both of you and your reluctance to listen to any of us in the field is one reason why we find ourselves bleeding sales talent and near another 5 year stock price low. Just leave.

 

Did you see the Proxy statement? The board is actually trying to RETAIN PB, not get rid of him. In Oct 2010 they gave him 265,734 RSUs, then in Feb 2011 they lavished on him another 345,942 RSUs. Even at a miniscule stock price of $2.20 this adds up to $1.5 million! WTF!!

I can't believe the BOD made this rediculous move. We need new leadership, not an over-paid incompetent. Frustrating...

 

Im sure there are companys in Milwaukee beating a path to Paul Berns door. Lets see, was he responsible for boner care? Not really, he was on the bus when genzyme jumped on. Was he responsible for BMS? No. BMS is a huge company and their methodology of an arms war wins in primary care was well established before Paul arrived. The first and only time he really has had an opportunity to carve out an identity as an executive is here at Allos. He has failed by every sense of the word. Pablo left when the time was right, he fired everyone around him who questioned the direction, strategy, and execution of his plan. What do we have to show for this egomaniacs leadership? A 5 year stock low, a sales team jumping at any opportunity to leave, a marketing team that is dumber than Paul and lacks relevant experience, a medical affairs team indifferent to Pauls threats, and a board of directors who treat allos as Pauls personal play toy. The bottom line is the company is circling the drain with Paul and it might be too late to save it.

 

The problem is that there is no one that would want to take over a sinking ship and ruin their reputation.

 

Its over. Allos is dead. Move this company to lost civilizations.

 

AMAG turned us down as well.Paul will be fired this week. Watch and see.

 

Paul never had a clue. He needs to do whats right LEAVE!! Lets face it he hasn't done anything to help the company only destroy the staff, product, and health provides perception of us, so if he leaves it can ONLY GET MUCH BETTER! Paul I hope you are reading this, Pack you things,, YOU MUST LEAVE!!! Go back to Wisconsin, and enjoy yourself in the home you never moved from...

 

Paul has left the building!!

 

why, where did he go?